Friday, January 15, 2021

COVID-19 as the Leading Cause of Death in the United States?

Viewpoint

December 17, 2020

COVID-19 as the Leading Cause of Death in the United States

Steven H. Woolf, MD, MPH1; Derek A. Chapman, PhD1,2; Jong Hyung Lee, MS2

1Center on Society and Health, Virginia Commonwealth University, Richmond

2Division of Epidemiology, Department of Family Medicine and Population Health, Virginia Commonwealth University, Richmond JAMA. 2021;325(2):123-124. doi:10.1001/jama.2020.24865

JAMA. 2021;325(2):123-124. doi:10.1001/jama.2020.24865

COVID-19 Resource Center

The current exponential increase in coronavirus disease 2019 (COVID-19) is reaching a calamitous scale in the United States, potentially overwhelming the health care system and causing substantial loss of life. The news media dutifully report each day’s increase in new cases and deaths, but putting these numbers in perspective may be difficult. The daily US mortality rate for COVID-19 deaths is equivalent to the September 11, 2001, attacks, which claimed 2988 lives,1 occurring every 1.5 days, or 15 Airbus 320 jetliners,2 each carrying 150 passengers, crashing every day.

A helpful approach to put the effects of the pandemic in context is to compare COVID-19–related mortality rates with the leading causes of death that, under ordinary circumstances, would pose the greatest threat to different age groups.3 The conditions listed in the Table include the 3 leading causes of death in each of the 10 age groups from infancy to old age. Using data from the Centers for Disease Control and Prevention, the Table shows mortality rates for these conditions during the period of March through October 20184 (the most recent year for which detailed cause-of-death data are available) with COVID-19 mortality rates during March through October 2020.5

The Table shows that by October 2020 COVID-19 had become the third leading cause of death for persons aged 45 through 84 years and the second leading cause of death for those aged 85 years or older. Adults 45 years or older were more likely to die from COVID-19 during those months than from chronic lower respiratory disease, transport accidents (eg, motor vehicle fatalities), drug overdoses, suicide, or homicide. In contrast, for individuals younger than age 45 years, other causes of death, such as drug overdoses, suicide, transport accidents, cancer, and homicide exceeded those from COVID-19.

Especially for older adults, the threat from COVID-19 may be even greater, for 3 reasons. First, the Table presents the aggregate 8-month mortality rate for COVID-19, not the current mortality rate, which has been increasing rapidly. Between November 1, 2020, and December 13, 2020, the 7-day moving average for daily COVID-19 deaths tripled, from 826 to 2430 deaths per day, and if this trend is unabated will soon surpass the daily rate observed at the height of the spring surge (2856 deaths per day on April 21, 2020).6 As occurred in the spring, COVID-19 has become the leading cause of death in the United States (daily mortality rates for heart disease and cancer, which for decades have been the 2 leading causes of death, are approximately 1700 and 1600 deaths per day, respectively4). With COVID-19 mortality rates now exceeding these thresholds, this infectious disease has become deadlier than heart disease and cancer, and its lethality may increase further as transmission increases with holiday travel and gatherings and with the intensified indoor exposure that winter brings.

Second, the reported number of COVID-19 deaths underestimates the excess deaths produced by the pandemic. Due to reporting delays and miscoding of COVID-19 deaths and an increase in non–COVID-19 deaths caused by disruptions produced by the pandemic, excess deaths are estimated to be 50% higher than publicly reported COVID-19 death counts.7 Third, COVID-19 is unlike other causes of death in the Table because it is communicable; individuals who die from homicide or cancer do not transmit the risk of morbidity or mortality to those nearby. Every COVID-19 death signals the possibility of more deaths among close contacts.

The failure of the public and its leaders to take adequate steps to prevent viral transmission has made the nation more vulnerable, allowing COVID-19 to become the leading cause of death in the United States, particularly among those aged 35 years or older. Much of this escalation was preventable, as is true for many deaths to come. The prospect of a vaccine offers hope for 2021, but that solution will not come soon enough to avoid catastrophic increases in COVID-19–related hospitalizations and deaths. The need for the entire population to take the disease seriously—notably to wear masks and maintain social distance—could not be more urgent.


Weekly Updates by Select Demographic and Geographic Characteristics Provisional Death Counts for Coronavirus Disease 2019 (COVID-19)

Daily Updates of Totals by Week and State

Weekly Updates by Select Demographic and Geographic Characteristics

Health Disparities: Race and Hispanic Origin

Excess Deaths Associated with COVID-19

Index of Available Data Files

Technical Notes

Updated: January 13, 2021 





Wednesday, December 23, 2020

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa

Houriiyah Tegally, Eduan Wilkinson, Marta Giovanetti, Arash Iranzadeh, Vagner Fonseca, Jennifer Giandhari, Deelan Doolabh, Sureshnee Pillay, Emmanuel James San, Nokukhanya Msomi, Koleka Mlisana, Anne von Gottberg, Sibongile Walaza, Mushal Allam, Arshad Ismail, Thabo Mohale, Allison J Glass, Susan Engelbrecht, Gert Van Zyl, Wolfgang Preiser, Francesco Petruccione, Alex Sigal, Diana Hardie, Gert Marais, Marvin Hsiao, Stephen Korsman, Mary-Ann Davies, Lynn Tyers, Innocent Mudau, Denis York, Caroline Maslo, Dominique Goedhals, Shareef Abrahams, Oluwakemi Laguda-Akingba, Arghavan Alisoltani-Dehkordi, Adam Godzik, Constantinos Kurt Wibmer, Bryan Trevor Sewell, Jose Lourenco, Luiz Carlos Junior Alcantara, Sergei L Kosakovsky Pond, Steven Weaver, Darren Martin, Richard J Lessells, Jinal N Bhiman, Carolyn Williamson, View ORCID ProfileTulio de de Oliveira


This article is a preprint and has not been certified by peer review [what does this mean?]. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.

Abstract

Continued uncontrolled transmission of the severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) in many parts of the world is creating the conditions for significant virus evolution. Here, we describe a new SARS-CoV-2 lineage (501Y.V2) characterised by eight lineage-defining mutations in the spike protein, including three at important residues in the receptor-binding domain (K417N, E484K and N501Y) that may have functional significance. This lineage emerged in South Africa after the first epidemic wave in a severely affected metropolitan area, Nelson Mandela Bay, located on the coast of the Eastern Cape Province. This lineage spread rapidly, becoming within weeks the dominant lineage in the Eastern Cape and Western Cape Provinces. Whilst the full significance of the mutations is yet to be determined, the genomic data, showing the rapid displacement of other lineages, suggest that this lineage may be associated with increased transmissibility.


The health secretary also said two cases have been detected of another new variant of the coronavirus in the UK.

Both were contacts of cases who have travelled from South Africa over the past few weeks, he said.

He said: "This new variant is highly concerning because it is yet more transmissible and it appears to have mutated further than the new variant that has been discovered in the UK."

The health secretary said both cases and close contacts of the cases have been quarantined. 

There are immediate restrictions on travel from South Africa and the government is telling those who have been in contact with anyone who has been in South Africa in the last fortnight that they must quarantine.

The measures were temporary, he said, while the new variant was analysed by scientists at the government's research centre at Porton Down.


video is grave!


Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England

Status: report | First online: 23-12-2020 | Last update: 23-12-2020

Authors: Nicholas Davies*, Rosanna C Barnard1, Christopher I Jarvis1, Adam J Kucharski1, James D Munday1, Carl A.B. Pearson1, Timothy W Russell1, Damien C Tully1, Sam Abbott, Amy Gimma, William Waites, Kerry LM Wong, Kevin van Zandvoort, CMMID COVID-19 working group, Rosalind M Eggo, Sebastian Funk, Mark Jit, Katherine E Atkins & W John Edmunds.

* corresponding author1 contributed equally

This study has not yet been peer reviewed.

A novel SARS-CoV-2 variant, VOC 202012/01, emerged in southeast England in November 2020 and appears to be rapidly spreading towards fixation. We fitted a two-strain mathematical model of SARS-CoV-2 transmission to observed COVID-19 hospital admissions, hospital and ICU bed occupancy, and deaths; SARS-CoV-2 PCR prevalence and seroprevalence; and the relative frequency of VOC 202012/01 in the three most heavily affected NHS England regions (South East, East of England, and London). We estimate that VOC 202012/01 is 56% more transmissible (95% credible interval across three regions 50-74%) than preexisting variants of SARS-CoV-2. We were unable to find clear evidence that VOC 202012/01 results in greater or lesser severity of disease than preexisting variants. Nevertheless, the increase in transmissibility is likely to lead to a large increase in incidence, with COVID-19 hospitalisations and deaths projected to reach higher levels in 2021 than were observed in 2020, even if regional tiered restrictions implemented before 19 December are maintained. Our estimates suggest that control measures of a similar stringency to the national lockdown implemented in England in November 2020 are unlikely to reduce the effective reproduction number Rt to less than 1, unless primary schools, secondary schools, and universities are also closed. We project that large resurgences of the virus are likely to occur following easing of control measures. It may be necessary to greatly accelerate vaccine roll-out to have an appreciable impact in suppressing the resulting disease burden.


Covid-19: Chaotic decision making and failure to communicate undermined government response, says report

BMJ 2020; 371 doi: https://www.bmj.com/content/371/bmj.m4940 (Published 22 December 2020)

Cite this as: BMJ 2020;371:m4940

Shaun Griffin Author affiliations Ministers must improve the way they use and communicate advice from scientists or risk repeating mistakes made earlier in the coronavirus pandemic, a think tank has warned.

A report from the Institute for Government outlined a series of errors it said the government made in the past 10 months: from the lack of a coherent strategy when lockdown restrictions were lifted in May to its failure to consult scientists on “epidemiologically illiterate” policies, such as the “Eat Out to Help Out” scheme, and its delay in consulting the Scientific Advisory Group for Emergencies on the return of students to universities.1

Many such problems had been seen in the government’s handling of past crises, such as the outbreaks of bovine spongiform encephalopathy, foot and mouth disease, and H1N1 “swine” flu, said the report. These included the blurring of policy decisions and expert advice, relying on uncertain modelling and “groupthink,” and a lack of transparency in explaining how evidence and advice were used.

Tom Sasse, associate director at the institute and an author of the report, said that the pandemic response had so far “too often been undermined by misunderstanding the role of science advice and using it inconsistently.” He added, “Looking to scientists to make judgments only politicians can make has contributed to the government delaying the first lockdown.

“Haphazard communication of key public health messages switched between alarm and reassurance while failing to drive home key points such as the risk of gathering indoors.” Furthermore, a lack of transparent evidence had undermined confidence in government policies, such as the plan to reopen schools in June, he said.

“Ministers repeatedly insisted they were ‘following the science.’ But the decision over Christmas bubbles is yet another example of the government delaying decision making and failing to use scientific advice well—or to communicate a consistent message to the public,” said Sasse. “There are difficult months of restrictions and vaccine rollout to come in 2021. Ministers must avoid repeating the damaging mistakes of this year.”

SAGE role praised The report noted that, despite being an ad hoc body, SAGE had responded well under pressure. Its co-chairs, Patrick Vallance and Chris Whitty, adapted the group in response to the crisis when it was not designed to take on such a prolonged role.

SAGE has met more than 70 times to discuss covid, whereas in previous crises it met no more than five times. After the first few weeks the Department of Health and Social Care for England and Public Health England, and their devolved equivalents, would have been expected to take over the ongoing response, but this did not happen. Instead, Number 10 opted to retain greater control and keep SAGE running, even after the high level Cabinet Office group stopped meeting.

Sasses said that although there were “valid criticisms about the range of disciplines represented in [SAGE’s] membership . . . the greater problem has been chaotic decision making from the top of government.” This has repeatedly created problems in how SAGE’s work is commissioned and how its members understand the way their advice is used.

Recommendations The institute called on covid cabinet committees to better integrate scientific, economic, and other advice in making decisions in the coming months and for ministers to explain clearly how trade-offs are made. The government must also make more use of scientist led briefings to explain to the public the reasons for its measures.

The institute also said that the Treasury should publish economic analyses of the costs and effects on wellbeing of implementing, or not implementing, public health restrictions.

In the longer term the government should strengthen science capability across the civil service, develop strong working relations with ministerial scientific advisers, and make more consistent use of groups tasked with finding weaknesses in crisis response plans.


Science advice in a crisis

Published: 18 December 2020

Ministers must improve the way they use and communicate science advice or risk repeating mistakes made during the coronavirus crisis.

This paper draws on interviews with key players including current and former officials, scientific advisers and SAGE members.

While ministers have faced extraordinarily difficult choices, the government’s response to the pandemic has too often been undermined by misunderstanding the role of science advice and using it inconsistently. Looking to scientists to make judgements only politicians can make – captured in ministers’ misleading mantra that they were “following the science” – contributed to the government delaying the first lockdown.

The government failed to bring different strands of advice together to form a coherent strategy when restrictions were lifted from May. Scientists were not consulted about policies including the Eat Out to Help Out scheme and thought they were epidemiologically illiterate, and SAGE was consulted too late about the return of university students to offer useful advice.

Haphazard communication of key public health messages has switched between alarm and reassurance, while failing to drive home key points such as the risk of gathering indoors. The government has also failed to explain the trade-offs behind its policies, while a lack of transparent evidence undermined confidence in specific policies, such as the plan to reopen schools in June.

SAGE itself has responded well under substantial pressure and despite being designed as an ad-hoc body. While there are valid criticisms about the range of disciplines represented in its membership, with discussion often dominated by epidemiologists and modellers and a lack of external public health experts, the greater problem has been chaotic decision making from the top of government. This has repeatedly created problems in how SAGE work is commissioned and how its members understand the way their advice is used by government.

As it rolls out a vaccine, the government will continue to face difficult decisions about how to control the virus in the coming months. The report sets out how it can make immediate improvements to the way it uses science advice and makes recommendations for future crises.

Science Advice in a Crisis December 2020


covid Galveston County Texas DEATHS 204 to date

Galveston County:

Confirmed Cases 17,945

Probable Cases 935

Fatalities 204

Active Cases (Estimated) 2,971

Recovered (Estimated) 14,802



Preliminary genomic characterisation of an emergent SARS-CoV-2 lineage in the UK defined by a novel set of spike mutations

Report written by: Andrew Rambaut1, Nick Loman2, Oliver Pybus3, Wendy Barclay4, Jeff Barrett5, Alesandro Carabelli6, Tom Connor7, Tom Peacock4, David L Robertson8, Erik Volz4, on behalf of COVID-19 Genomics Consortium UK (CoG-UK)9.

University of Edinburgh University of Birmingham University of Oxford Imperial College London Wellcome Trust Sanger Institute University of Cambridge Cardiff University MRC-University of Glasgow Centre for Virus Research https://www.cogconsortium.uk 1.2k

Summary 

Recently a distinct phylogenetic cluster (named lineage B.1.1.7) was detected within the COG-UK surveillance dataset. This cluster has been growing rapidly over the past 4 weeks and since been observed in other UK locations, indicating further spread.

Several aspects of this cluster are noteworthy for epidemiological and biological reasons and we report preliminary findings below. In summary: 

The B.1.1.7 lineage accounts for an increasing proportion of cases in parts of England. The number of B.1.1.7 cases, and the number of regions reporting B.1.1.7 infections, are growing. 

B.1.1.7 has an unusually large number of genetic changes, particularly in the spike protein. 

Three of these mutations have potential biological effects that have been described previously to varying extents:

Mutation N501Y is one of six key contact residues within the receptor-binding domain (RBD) and has been identified as increasing binding affinity to human and murine ACE2. 

The spike deletion 69-70del has been described in the context of evasion to the human immune response but has also occurred a number of times in association with other RBD changes. 

Mutation P681H is immediately adjacent to the furin cleavage site, a known location of biological significance. The rapid growth of this lineage indicates the need for enhanced genomic and epidemiological surveillance worldwide and laboratory investigations of antigenicity and infectivity.

Background 

The two earliest sampled genomes that belong to the B.1.1.7 lineage were collected on 20-Sept-2020 in Kent and another on 21-Sept-2020 from Greater London. B.1.1.7 infections have continued to be detected in the UK through early December 2020. Genomes belonging to lineage B.1.1.7 form a monophyletic clade that is well supported by a large number of lineage-defining mutations (Figure 1). As of 15th December, there are 1623 genomes in the B.1.1.7 lineage. Of these 519 were sampled in Greater London, 555 in Kent, 545 in other regions of the UK including both Scotland and Wales, and 4 in other countries...

snip...see full text;






to be continued...tss

COVID-19 as the Leading Cause of Death in the United States?

Viewpoint December 17, 2020 COVID-19 as the Leading Cause of Death in the United States Steven H. Woolf, MD, MPH1; Derek A. Chapman, PhD1,2;...